fda approved glp-1 receptor agonists of GLP-1RAs for the treatment of type 2 diabetes. US Food How Employers Can Optimize Benefits

GLP-1 receptor activation GLP-1 receptor activation was determined using an in vitro bioluminescence resonance energy transfer (BRET)-based assay that measures changes in intracellular cyclic-AMP levels

Similar to GIP, GLP-1 led to a notable suppression of the bone resorption marker CTX-1

Similarly, interrupted use was associated with increased MACE risk, with IRRs of 1.12 for one year and 1.16 for two years of interruption, with effect sizes differing modestly depending on prior treatment duration

Tirzepatide, a dual agonist for GLP-1 and GIP receptors, effectively promotes weight loss and improves metabolic parameters by influencing insulin secretion, appetite regulation, and gastric emptying

The mean [95% CI] reduction in HbA 1c was 0.7%point [0.51